Tenax Therapeutics (TENX) Preferred Stock Liabilities (2012)
Tenax Therapeutics (TENX) posted quarterly Preferred Stock Liabilities of $429978.0 for Q4 2012, down 78.89% on a QoQ basis from $2.0 million in Q3 2012.
Tenax Therapeutics (TENX) Preferred Stock Liabilities (2012) Analysis & Trends
Tenax Therapeutics has reported Preferred Stock Liabilities for 1 years, with the latest figure at $429978.0 in Q4 2012.
- Preferred Stock Liabilities for Q4 2012 came in at $429978.0, changed N/A year-over-year; the trailing twelve-month figure through Oct 2012 was $429978.0 (changed N/A YoY), and the FY2012 annual result was $1.2 million, changed N/A from the prior year.
- Preferred Stock Liabilities retreated to $429978.0 in Q4 2012, from $2.0 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $3.9 million in Q1 2012 and troughed at $429978.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2012 | 429,978.00 |
| Jul 31, 2012 | 2.04 Mn |
| Apr 30, 2012 | 1.25 Mn |
| Jan 31, 2012 | 3.92 Mn |